Mark Anderson, M.D., FACS, vice...
Ventricular Assist Devices (VAD)
This channel includes news and new technology innovations for Ventricular Assist Devices (VAD). VADs are a type of hemodynamic support device that helps increase blood flow in people who have ventricles that don't work properly.
-
-
Michael Amponsah, M.D., FACC, an interventional cardiologist at...
-
The scientific journal Nature recently published an article from Munich University Hospital which describes the long-term survival of baboons that had received a heart transplant from genetically...
-
Navin Kapur, M.D., discusses the results of the FDA STEMI Door-to-Unloading (DTU) safety and...
Sponsored Content | Videos | January 10, 2019
...
Sponsored Content | Videos | Hemodynamic Support Devices | December 13, 2018
A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it were greatly alleviate shortages of donor human hearts.
News | Cardiovascular Surgery | December 11, 2018
December 11, 2018 — The scientific journal...
A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC 2018. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at ACC earlier this year.
Feature | Heart Failure | October 19, 2018
October 19, 2018 — Abbott announced today that the HeartMate 3 Left Ventricular Assist Device (LVAD) has received U....
News | Hemodynamic Support Devices | September 20, 2018
September 19, 2018 — Abiomed Inc. announces its initiatives at the 30th Transcatheter Cardiovascular Therapeutics (...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ)...
Videos | Hemodynamic Support Devices | August 31, 2018
Behnam Tehrani, M.D., FSCAI, director of the cardiac cath lab, INOVA Heart and Vascular Institute, Fairfax, Va.,...
Technology | Ventricular Assist Devices (VAD) | July 17, 2018
July 17, 2018 — Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for a less-invasive...
Image courtesy of CorWave
News | Ventricular Assist Devices (VAD) | July 11, 2018
July 11, 2018 — French-based CorWave announced that its CALYPSO program has received 14 million euros to develop...
Two versions of the Abiomed Impella percutaneous ventricular assist device displayed at ACC 2018. Impella is the only device that currently has a FDA indication for use in cardiogenic shock.
Feature | Hemodynamic Support Devices | July 08, 2018 | Emmanouil S. Brilakis, M.D., Ph.D., FSCAI and Srihari S. Naidu, M.D., FSCAI
Cardiogenic shock (CS) is a low-cardiac-output state resulting in life-threatening end-organ hypoperfusion and hypoxia...
William O'Neill, M.D., unveils the Detroit Cardiogenic Shock Initiative at Henry Ford Hospital. The program uses new protocols to reduce cardiogenic shock mortality by 50 percent by using early hemodyanmic support.
Feature | Hemodynamic Support Devices | June 22, 2018 | Dave Fornell, Editor
About 50 percent of patients in cardiogenic shock do not survive, and account for about 90,000 heart attack patients...
Feature | Ventricular Assist Devices (VAD) | June 04, 2018
June 4, 2018 — The U.S. Food and Drug Administration said Medtronic initiated a Class 1 recall all 204,017 of its...
